60 related articles for article (PubMed ID: 18787978)
1. We need to talk about Candida tropicalis: Virulence factors and survival mechanisms.
Dos Santos MM; Ishida K
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37505455
[TBL] [Abstract][Full Text] [Related]
2. One Case of Drug-Resistant Invasive Fungal Infection after Myelodysplastic Syndrome Chemotherapy.
Chen Y; Yang X; Wu X; Wu Y; Li Y
Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868888
[TBL] [Abstract][Full Text] [Related]
3. A potent candicidal peptide designed based on an encrypted peptide from a proteinase inhibitor.
Almeida LHO; Ramalho SR; Almeida CV; Gutierrez CO; Sardi JCO; Miranda A; Oliveira RA; Rezende SB; Crusca E; Franco OL; Oliveira CFR; Cardoso MH; Macedo MLR
Biochim Biophys Acta Gen Subj; 2024 May; 1868(5):130583. PubMed ID: 38360076
[TBL] [Abstract][Full Text] [Related]
4. Oral candida lesions and Candida tropicalis: Potential prognostic markers in end-of-life cancer patients.
Shimosato M; Kada S; Yase E; Sakane N
Spec Care Dentist; 2024 Jan; ():. PubMed ID: 38168741
[TBL] [Abstract][Full Text] [Related]
5. Correlation of atherogenesis with an infection of Candida albicans.
Nurgeldiyeva MJ; Hojakuliyev BG; Muhammedov MB
Int J Clin Exp Med; 2014; 7(8):2137-43. PubMed ID: 25232398
[TBL] [Abstract][Full Text] [Related]
6. Altered oral microbiome in Sudanese Toombak smokeless tobacco users carries a newly emerging risk of squamous cell carcinoma development and progression.
Sami A; Elimairi I; Ryan CA; Stanton C; Patangia D; Ross RP
Sci Rep; 2023 Apr; 13(1):6645. PubMed ID: 37095112
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of virulence factors and azole resistance mechanisms of
Jahanshiri Z; Manifar S; Hatami F
Iran J Microbiol; 2023 Feb; 15(1):163-173. PubMed ID: 37069909
[TBL] [Abstract][Full Text] [Related]
8. Candida species and oral mycobiota of patients clinically diagnosed with oral thrush.
Karajacob AS; Azizan NB; Al-Maleki ARM; Goh JPE; Loke MF; Khor HM; Ho GF; Ponnampalavanar S; Tay ST
PLoS One; 2023; 18(4):e0284043. PubMed ID: 37068057
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of Morin Against
Abirami G; Alexpandi R; Durgadevi R; Kannappan A; Veera Ravi A
Front Microbiol; 2020; 11():561298. PubMed ID: 33193145
[No Abstract] [Full Text] [Related]
10. Comprehensive biomedical applications of low temperature plasmas.
Duarte S; Panariello BHD
Arch Biochem Biophys; 2020 Oct; 693():108560. PubMed ID: 32857998
[TBL] [Abstract][Full Text] [Related]
11. RELATED FACTORS FOR COLONIZATION BY Candida SPECIES IN THE ORAL CAVITY OF HIV-INFECTED INDIVIDUALS.
Menezes Rde P; Borges AS; Araujo LB; Pedroso Rdos S; Röder DV
Rev Inst Med Trop Sao Paulo; 2015; 57(5):413-9. PubMed ID: 26603229
[TBL] [Abstract][Full Text] [Related]
12. Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs.
Zarei Mahmoudabadi A; Rezaei-Matehkolaei A; Navid M; Torabizadeh M; Mazdarani S
J Nephropathol; 2015 Jul; 4(3):77-84. PubMed ID: 26312235
[TBL] [Abstract][Full Text] [Related]
13. Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.
Seifi Z; Zarei Mahmoudabadi A; Zarrin M
Jundishapur J Microbiol; 2015 Mar; 8(3):e20162. PubMed ID: 25861438
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Antifungal Activity against Candida albicans and Electron Parameters of Selected N-Heterocyclic Thioamides.
Stachowicz J; Krajewska-Kułak E; Lukaszuk C; Niewiadomy A
Indian J Pharm Sci; 2014 Jul; 76(4):287-98. PubMed ID: 25284926
[TBL] [Abstract][Full Text] [Related]
15. Insights into Candida tropicalis nosocomial infections and virulence factors.
Negri M; Silva S; Henriques M; Oliveira R
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1399-412. PubMed ID: 22037823
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples.
Pereira CA; da Costa AC; Machado AK; Beltrame Júnior M; Zöllner MS; Junqueira JC; Jorge AO
Mycopathologia; 2011 Feb; 171(2):103-9. PubMed ID: 20703942
[TBL] [Abstract][Full Text] [Related]
17. Differential resistance to oxidants and production of hydrolytic enzymes in Candida albicans.
Abegg MA; Lucietto R; Alabarse PV; Mendes MF; Benfato MS
Mycopathologia; 2011 Jan; 171(1):35-41. PubMed ID: 20632209
[TBL] [Abstract][Full Text] [Related]
18. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Negri M; Martins M; Henriques M; Svidzinski TI; Azeredo J; Oliveira R
Mycopathologia; 2010 Mar; 169(3):175-82. PubMed ID: 19851885
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.
da Costa KR; Ferreira JC; Komesu MC; Candido RC
Mycopathologia; 2009 Feb; 167(2):73-9. PubMed ID: 18787978
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
